SLICC Damage | Total†, n = 247 (%) | Caucasian, n = 80 (%) | Non-Caucasian, n = 150 (%) | Asian, n = 61 (%) | Black, n = 44 (%) | South Asian, n = 37 (%) |
---|---|---|---|---|---|---|
Damage, n = 259 | 102 (39) | 29 (33) | 63 (41) | 23 (38) | 17 (39) | 20 (51) |
Ocular | 39 (38) | 10 (34) | 24 (38) | 11 (48) | 2 (12) | 9 (45) |
Cataracts | 39 | 10 | 24 | 11 | 2 | 9 |
Retinal change | 0 | 0 | 0 | 0 | 0 | 0 |
Optic atrophy | 0 | 0 | 0 | 0 | 0 | 0 |
MSK | 23 (23) | 14 (48) | 15 (24) | 6 (26) | 3 (18) | 12 (60) |
Avascular necrosis | 23 | 14 | 15 | 6 | 3 | 12 |
Endocrine | 8 (7) | 3 (10) | 4 (6) | 0 (0) | 4 (24) | 0 (0) |
Diabetes | 6 | 2 | 3 | 0 | 3 | 0 |
Premature gonadal failure | 2 | 1 | 1 | 0 | 1 | 0 |
Cardiopulmonary | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Cardiac infarction | 0 | 0 | 0 | 0 | 0 | 0 |
Skin | 3 (3) | 1 (3) | 2 (3) | 1 (4) | 1 (6) | 0 (0) |
Tissue infarction | 3 | 1 | 2 | 1 | 1 | 0 |
Significant soft tissue loss | 0 | 0 | 0 | 0 | 0 | 0 |
Renal | 6 (6) | 0 (0) | 6 (10) | 2 (9) | 2 (12) | 0 (0) |
Glomerular filtration rate < 50% | 4 | 0 | 4 | 1 | 2 | 0 |
Proteinuria, > 3.5 g/24 h | 2 | 0 | 1 | 0 | 1 | 0 |
Endstage renal disease | 1 | 0 | 1 | 1 | 0 | 0 |
Neurologic | 12 (12) | 2 (7) | 11 (17) | 2 (9) | 3 (18) | 2 (10) |
Cognitive impairment | 5 | 0 | 5 | 1 | 2 | 2 |
Seizures | 7 | 2 | 5 | 1 | 2 | 1 |
Cerebral vascular accident | 9 | 1 | 8 | 1 | 3 | 1 |
Cranial neuropathy | 0 | 0 | 0 | 0 | 0 | 0 |
Transverse myelitis | 1 | 0 | 1 | 1 | 0 | 0 |
Malignancy | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
↵† Organ-specific damage data available on 247 of the 259 patients. Patients with mixed ethnicity (n = 17) are not included in the ethnic subgroups but are included in the total.